Observational Study
Copyright ©The Author(s) 2025.
World J Clin Pediatr. Sep 9, 2025; 14(3): 102309
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.102309
Table 1 Baseline characteristics and characteristics of the examined cases, n (%)/mean ± SD/median (IQR)
Characteristics
Total (n = 97)
Age on intubation (days)
Median (IQR)1 (1–2)
Range1–10
Intubation since birth
Yes
65 (67.0)
No32 (33.0)
Sex
Male66 (68.0)
Female31 (32.0)
Birth weight (kg)
mean ± SD
2.84 ± 0.45
Range1.89–4.5
Weight for age
Appropriate for GA (2.5 kg or more)
76 (78.4)
Small for GA (less than 2.5 kg)21 (21.6)
Mode of delivery
Cesarean section83 (85.6)
Normal vaginal delivery14 (14.4)
APGAR score at 1 minute
Median (IQR)3 (1–3)
Range0-7
APGAR score at 5 minutes
Median (IQR)7 (6–8)
Range2–10
Resuscitation
Positive pressure ventilation35 (36.1)
Tactile stimulation12 (12.4)
Intubation50 (51.5)
Table 2 Pepsin in sample A, B, and C of the studied cases, n (%)
Characteristics
Total (n = 97)
Sample A ETA pepsin (ng/mL)
Median (IQR)0.87 (0.11–2.58)
Range0.01–31
Pepsin detection in sample A
Not detected21 (21.6)
Detected76 (78.4)
Sample B ETA pepsin (ng/mL)
Median (IQR)0.84 (0.23–2.68)
Range0.01–12.5
Pepsin detection in sample B
Not detected18 (18.8)
Detected78 (81.3)
Sample C ETA pepsin (ng/mL)
Median (IQR)0.43 (0.05–1.63)
Range0.01–8.68
Pepsin detection in sample C
Not detected22 (31.9)
Detected47 (68.1)
Table 3 Relation of pepsin detection in sample A, B, and C with endotracheal aspirate culture of the studied cases, n (%)

Pepsin detection in sample A
Test value
P value
No detection (n = 21)
Detected (n = 76)
ETA cultureNot done5 (23.8)8 (10.5)4.09610.129
No growth10 (47.6)30 (39.5)
Positive6 (28.6)38 (50)
Pepsin detection in sample B
ETA cultureNot done2 (11.1)11 (14.1)1.03910.595
No growth6 (33.3)34 (43.6)
Positive10 (55.6)33 (42.3)
Pepsin detection in sample C
ETA cultureNot done3 (13.6)4 (8.5)0.5060.776
No growth9 (40.9)22 (46.8)
Positive10 (45.5)21 (44.7)
Table 4 Duration of hospital stay and outcome of the studied cases, n (%)
Characteristics
Total (n = 97)
Duration of hospital stay (days)
Median (IQR)15 (10–22)
Range4–35
Outcome
Died38 (39.2)
Discharged59 (60.8)
Table 5 Relation of pepsin detection in sample B with pepsin levels and pepsin detection in sample A and sample C of the studied cases, n (%)

Pepsin detection in sample B
Test value
P value
No detection (n = 18)
Detected (n = 78)
Sample A ETA pepsin (ng/mL)-1.3140.189
Median (IQR)
0.48 (0.02–1.9)0.94 (0.28–2.67)
Range0.01–7.270.01–31
Pepsin detection in sample A3.7520.053
No detection
7 (38.9)14 (17.9)
Detected11 (61.1)64 (82.1)
Sample C ETA pepsin (ng/mL)-1.7940.073
Median (IQR)
0.03 (0.01–1.43)0.51 (0.06–1.73)
Range0.01–4.020.01–8.68
Pepsin detection in sample C4.4940.034a
No detection
7 (58.3)15 (26.8)
Detected5 (41.7)41 (73.2)
Table 6 Correlation of pepsin in sample A, B and C with other studied parameters among the studied cases
Sample A ETA pepsin (ng/mL)
Sample B ETA pepsin (ng/mL)
Sample C ETA pepsin (ng/mL)
r
P value
r
P value
r
P value
Age on intubation (days)-0.0270.7910.0820.429-0.1700.164
Birth weight0.0100.9190.1550.132-0.1370.261
APGAR score at 1 minute-0.0820.4260.0270.7950.0080.951
APGAR score at 5 minutes-0.0200.847-0.0620.5490.0870.476
Proton pump inhibitor (days)-0.0040.9810.0540.748-0.0490.816
Prokinetic drugs (days)0.0050.976-0.0500.784-0.2300.259
Duration of MV (days)0.0800.4380.1300.208-0.1290.292
FiO20.1660.1040.2030.047a0.1930.112
Amount of feeding (mL/day)-0.2100.039a-0.2340.022a-0.2670.027a
Duration of hospital stay (days)0.0310.7660.2880.004a0.5590.000a